Frequency of Voids at 12 Weeks Baseline to 12 weeks [clinicaltrials_resource:53f1f1d7aef357649cfd069ac1911fa0]
To demonstrate that the Urgent PC system is as effective as or more effective (noninferior) than tolterodine (Detrol LA) in changing the frequency of urinary voids per day after 12 weeks of therapy. The voiding diaries completed at 12 weeks were compared to the baseline voiding diaries.
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
Frequency of Voids at 12 Weeks Baseline to 12 weeks [clinicaltrials_resource:53f1f1d7aef357649cfd069ac1911fa0]
To demonstrate that the Urgent PC system is as effective as or more effective (noninferior) than tolterodine (Detrol LA) in changing the frequency of urinary voids per day after 12 weeks of therapy. The voiding diaries completed at 12 weeks were compared to the baseline voiding diaries.
Bio2RDF identifier
53f1f1d7aef357649cfd069ac1911fa0
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:53f1f1d7aef357649cfd069ac1911fa0
measure [clinicaltrials_vocabulary:measure]
Frequency of Voids at 12 Weeks
time frame [clinicaltrials_vocabulary:time-frame]
Baseline to 12 weeks
description
To demonstrate that the Urgent ...... the baseline voiding diaries.
identifier
clinicaltrials_resource:53f1f1d7aef357649cfd069ac1911fa0
title
Frequency of Voids at 12 Weeks Baseline to 12 weeks
@en
type
label
Frequency of Voids at 12 Weeks ...... 1f1d7aef357649cfd069ac1911fa0]
@en